Tyrosine kinase inhibitors targeting vascular endothelial growth factor and the risk of aortic dissection—A pharmacovigilance analysis

There are concerns by the United States Food and Drug Administration (FDA) regarding a potential link between tyrosine kinase inhibitors targeting vascular endothelial growth factor (VEGF‐TKIs) and the risk of aortic dissection. Elevation of blood pressure induced by VEGF‐TKIs has been discussed as...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Pharmacol Res Perspect
Auteurs principaux: Dörks, Michael, Jobski, Kathrin, Herget‐Rosenthal, Stefan, Hoffmann, Falk, Douros, Antonios
Format: Artigo
Langue:Inglês
Publié: John Wiley and Sons Inc. 2021
Sujets:
Short Report
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7796803/
https://ncbi.nlm.nih.gov/pubmed/33421342
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/prp2.707
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires